Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.05 - $1.63 $30,557 - $47,436
-29,102 Reduced 16.31%
149,278 $168,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.73 $22,310 - $50,756
-18,592 Reduced 9.44%
178,380 $240,000
Q4 2022

Feb 14, 2023

SELL
$1.71 - $3.61 $21,821 - $46,067
-12,761 Reduced 6.08%
196,972 $366,000
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $21,684 - $98,494
-11,413 Reduced 5.16%
209,733 $516,000
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $100,651 - $425,758
-47,254 Reduced 17.61%
221,146 $540,000
Q4 2021

Feb 11, 2022

BUY
$14.7 - $28.67 $136,710 - $266,631
9,300 Added 3.59%
268,400 $4.1 Million
Q3 2021

Nov 12, 2021

SELL
$24.31 - $33.6 $252,167 - $348,532
-10,373 Reduced 3.85%
259,100 $7.37 Million
Q2 2021

Aug 12, 2021

BUY
$26.09 - $40.4 $2.54 Million - $3.94 Million
97,473 Added 56.67%
269,473 $9.09 Million
Q1 2021

May 17, 2021

BUY
$33.06 - $56.93 $138,852 - $239,106
4,200 Added 2.5%
172,000 $6.57 Million
Q4 2020

Feb 03, 2021

SELL
$39.09 - $57.4 $680,166 - $998,760
-17,400 Reduced 9.4%
167,800 $7.02 Million
Q3 2020

Nov 16, 2020

SELL
$28.43 - $44.67 $96,662 - $151,878
-3,400 Reduced 1.8%
185,200 $8.03 Million
Q2 2020

Aug 12, 2020

BUY
$11.71 - $30.29 $538,660 - $1.39 Million
46,000 Added 32.26%
188,600 $5.71 Million
Q1 2020

May 06, 2020

BUY
$7.64 - $27.5 $99,320 - $357,500
13,000 Added 10.03%
142,600 $1.95 Million
Q3 2019

Nov 12, 2019

BUY
$18.85 - $27.5 $501,410 - $731,500
26,600 Added 25.83%
129,600 $2.5 Million
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $264,024 - $399,304
15,200 Added 17.31%
103,000 $2.42 Million
Q1 2019

May 13, 2019

BUY
$10.65 - $25.75 $214,065 - $517,575
20,100 Added 29.69%
87,800 $2.06 Million
Q4 2018

Feb 11, 2019

BUY
$9.26 - $16.38 $10,186 - $18,018
1,100 Added 1.65%
67,700 $749,000
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $283,504 - $688,456
37,600 Added 129.66%
66,600 $1.11 Million
Q3 2017

Nov 01, 2017

BUY
$8.89 - $10.4 $257,810 - $301,600
29,000
29,000 $272,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.